HUB & Patient Support Solutions Complement Pre-Commercialisation Services

Working with manufacturers to implement end-to-end solutions that support all initiatives throughout the product lifecycle.
AscellaHealth EU
· 8 min read

AscellaHealth’s expanded HUB and patient support solutions for pharmaceutical manufacturers are recognised as the best-in-class outsourced solutions for successful medication access, compliance, and enhanced outcomes.

An increasing number of pharmaceutical manufacturers are choosing to rely upon AscellaHealth’s HUB and patient support services to unlock product potential and eliminate barriers to accessing therapy for individuals with specialty conditions and/or rare and orphan diseases.

When HUB and patient support solutions are paired with outsourced market access and pre-commercialisation services, AscellaHealth acts as an extension of the manufacturer’s existing market access team, resulting in maximised opportunities for ensuring patient access to therapy, optimising reimbursement at launch, and improving outcomes for patients. This powerful combination of resources represents end-to-end solutions that provide manufacturers with a “one-stop” resource, as differentiated from working with multiple outsourced vendors that focus upon narrower subsets of capabilities or specialties.

In this increasingly complex and rapidly evolving outsourcing landscape, our dedicated team of experienced professionals work collaboratively with the manufacturer’s in-house resources to implement our integrated solutions that support all initiatives throughout the product lifecycle.

Seven Critical Success Factors Throughout the Product Lifecycle of Specialty Drugs and Cell & Gene Therapies (CGTs)

We invite our readers to learn more about the issues that impact product launch, emphasising the importance of engaging our end-to-end HUB solutions early in the process – as soon as four to five years prior to launch.

  1. Engagement with a single, cross-functional Specialty Pharmacy (SP) solutions partner such as AscellaHealth, will prove to be beneficial for a variety of HUB services, including pre-commercialisation, launch, and market access solutions, plus centralised capabilities – including those performed by other outsourced vendors across the care continuum. This engagement will ease the administrative burden of managing multiple vendors and allowing manufacturers to work with a single resource for all programme and product launch milestones.

  2. A SP partner with HUB services, such as AscellaHealth should be: a) flexible, allowing manufacturers to choose only the services they need, whether it’s the full suite of capabilities or a bespoke package, b) data-driven, providing real-time, actionable data that emanates from one source to support real-world evidence and outcomes-based data management, c) complete, meeting manufacturers’ needs to shift away from multiple big box vendors and opt for an all-inclusive programme that offers full-service support and service, d) consultative, building a relationship with the manufacturer that demonstrates an understanding of their challenges and supports the development of solutions based upon active listening, e) customisable, positioned to respond to the unique requirements of manufacturers who express dissatisfaction with ‘off-the-shelf’ services that fail to address their unmet needs.

  3. Choosing AscellaHealth as a partner will provide you with novel pharmaceutical financial solutions backed by technology -- a critical requirement in this new era of expensive specialty medications and CGTs. Alleviating the challenges of funding these expensive treatments, this financial solution allows novel and potentially curative treatments to be brought to market to help rare disease patients.

  4. Our HUB services employ a consumer-focused, patient-centric approach, so manufacturers can proactively respond to market demands for higher levels of patient engagement in clinical decision-making and protocols. Empowering individuals with information and education and giving personalised guidance with a ‘human touch’, increases patient engagement, boosts satisfaction scores, and enhances the patient experience throughout the healthcare journey.

    To further optimise therapeutic outcomes, our care coordinators and expert call centre trained teams use technology-based tools and algorithms to break down barriers to medication access, streamline communications between prescriber, patient, and pharmacy, and reduce the time to fill for prescriptions.

  5. Comprehensive supply chain logistics capabilities are an essential component of HUB services ensuring the seamless flow of products from the point of production to the patient. As a SP partner, that specialises in rare diseases, our services are designed to optimise the supply chain for every type of pharmaceutical product and are built to scale in response to the size and growth of each individual product in our inventory.

  6. Exclusive international distribution options provide accurate and cost-effective services to ensure patient access to therapies whenever and wherever needed. Additionally, our programmes for specialty products offer high-touch attention to special handling requirements that span temperature control, fast turnaround times, and shipment tracking that supports uninterrupted therapy.

  7. Our HUB service teams are knowledgeable, experienced, thoroughly understand the market and are valuable allies in successful access strategies. AscellaHealth is fortunate to offer a skilled team of professionals who have the global reach and market awareness to craft optimal pricing strategies to support product launch.

Engage with an AscellaHealth Services Partner Early in the Process

It is important to leverage our HUB and patient support solutions during all phases of pre-commercialisation and market access – which can be as early as four to five years prior to product launch. Our growth strategies have been proven to deliver meaningful and tangible results, optimising patient engagement across the care journey, and advancing medication adherence and affordability.

As an independent resource for manufacturers, we continue to expand and refine our comprehensive HUB services and we constantly evolve in response to market changes.

To schedule a meeting to discuss our custom solutions for pharmaceutical manufacturers, please click here.

Loading cookie banner...